Evidence map›Paper›PMID 28035238›Full record

ArticleEvolutionary applications2017

Manipulating virulence factor availability can have complex consequences for infections.

Michael Weigert, Adin Ross-Gillespie, Anne Leinweber, Gabriella Pessi, Sam P Brown, Rolf Kümmerli

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Iron acquisition strategies in pseudomonads: mechanisms, ecology, and evolution.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Pyoverdine-Dependent Virulence ofFrontiers in microbiology · 2019
    Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Michael WeigertDepartment of Plant and Microbial Biology University of Zurich Zurich Switzerland; Microbiology Department of Biology I Ludwig Maximilians University Munich Martinsried Germany.
Adin Ross-GillespieDepartment of Plant and Microbial Biology University of Zurich Zurich Switzerland; Bioinformatics Core Facility SIB Swiss Institute of Bioinformatics Lausanne Switzerland.
Anne LeinweberDepartment of Plant and Microbial Biology University of Zurich Zurich Switzerland.
Gabriella PessiDepartment of Plant and Microbial Biology University of Zurich Zurich Switzerland.
Sam P BrownSchool of Biological Sciences Georgia Institute of Technology Atlanta Georgia USA.
Rolf KümmerliDepartment of Plant and Microbial Biology University of Zurich Zurich Switzerland.
University of Zurich · CHGeorgia Institute of Technology · USLudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the rise of bacterial resistance against antibiotics, we urgently need alternative strategies to fight infections. Some propose we should disarm rather than kill bacteria, through targeted disruption of their virulence factors. It is assumed that this approach (i) induces weak selection for resistance because it should only minimally impact bacterial fitness, and (ii) is specific, only interfering with the virulence factor in question. Given that pathogenicity emerges from complex interactions between pathogens, hosts and their environment, such assumptions may be unrealistic. To address this issue in a test case, we conducted experiments with the opportunistic human pathogen

Indexed as

antivirulence therapyGalleria mellonellahost effectsopportunistic pathogenpathogen fitnesspleiotropyPseudomonas aeruginosasiderophore

Identifiers

PMID28035238
PMCPMC5192820
OpenAlexW2556277156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.